197 related articles for article (PubMed ID: 15499067)
1. Nephrolithiasis associated with ceftriaxone therapy: a prospective study in 51 children.
Avci Z; Koktener A; Uras N; Catal F; Karadag A; Tekin O; Degirmencioglu H; Baskin E
Arch Dis Child; 2004 Nov; 89(11):1069-72. PubMed ID: 15499067
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
[TBL] [Abstract][Full Text] [Related]
3. Ceftriaxone associated nephrolithiasis: a prospective study in 284 children.
Mohkam M; Karimi A; Gharib A; Daneshmand H; Khatami A; Ghojevand N; Sharifian M
Pediatr Nephrol; 2007 May; 22(5):690-4. PubMed ID: 17226043
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis in a child.
Prince JS; Senac MO
Pediatr Radiol; 2003 Sep; 33(9):648-51. PubMed ID: 12830336
[TBL] [Abstract][Full Text] [Related]
5. Nephrolithiasis in a child with acute pyelonephritis. Ceftriaxone-induced nephrolithiasis and biliary pseudolithiasis.
Tasic V; Sofijanova A; Avramoski V
Pediatr Nephrol; 2005 Oct; 20(10):1510-1, 1512-3. PubMed ID: 16082553
[No Abstract] [Full Text] [Related]
6. Comparative evaluation of ceftriaxone- and cefotaxime-induced biliary pseudolithiasis or nephrolithiasis: A prospective study in 154 children.
Ustyol L; Bulut MD; Agengin K; Bala KA; Yavuz A; Bora A; Demiroren K; Dogan M
Hum Exp Toxicol; 2017 Jun; 36(6):547-553. PubMed ID: 27402682
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone-associated biliary pseudolithiasis in children.
Biner B; Oner N; Celtik C; Bostancioğlu M; Tunçbilek N; Güzel A; Karasalihoğlu S
J Clin Ultrasound; 2006 Jun; 34(5):217-22. PubMed ID: 16673364
[TBL] [Abstract][Full Text] [Related]
8. Biliary precipitation during ceftriaxone therapy: frequency and risk factors.
Soysal A; Eraşov K; Akpinar I; Bakir M
Turk J Pediatr; 2007; 49(4):404-7. PubMed ID: 18246742
[TBL] [Abstract][Full Text] [Related]
9. Complications of ceftriaxone-associated biliary pseudolithiasis and neprolithiasis: a case report.
Sienra MC; Pereira Núñez D; Pacheco H; Juambeltz C
Cir Pediatr; 2020 Jul; 33(3):149-152. PubMed ID: 32657101
[TBL] [Abstract][Full Text] [Related]
10. Early biliary pseudolithiasis during ceftriaxone therapy for acute pyelonephritis in children: a prospective study in 34 children.
Bonnet JP; Abid L; Dabhar A; Lévy A; Soulier Y; Blangy S
Eur J Pediatr Surg; 2000 Dec; 10(6):368-71. PubMed ID: 11215777
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic findings in ceftriaxone: associated biliary sludge and pseudolithiasis in children.
Ozturk A; Kaya M; Zeyrek D; Ozturk E; Kat N; Ziylan SZ
Acta Radiol; 2005 Feb; 46(1):112-6. PubMed ID: 15841750
[TBL] [Abstract][Full Text] [Related]
12. Re: Pediatric ceftriaxone nephrolithiasis.
Avci Z; Karadag A; Odemis E; Catal F
J Urol; 2005 Sep; 174(3):1153. PubMed ID: 16094092
[No Abstract] [Full Text] [Related]
13. Ceftriaxone-associated nephrolithiasis and biliary pseudolithiasis.
de Moor RA; Egberts AC; Schröder CH
Eur J Pediatr; 1999 Dec; 158(12):975-7. PubMed ID: 10592073
[TBL] [Abstract][Full Text] [Related]
14. Fasting and bed rest, even for a relatively short period, are risk factors for ceftriaxone-associated pseudolitiasis.
Murata S; Aomatsu T; Yoden A; Tamai H
Pediatr Int; 2015 Oct; 57(5):942-6. PubMed ID: 25907455
[TBL] [Abstract][Full Text] [Related]
15. Gallbladder and urinary tract precipitations associated with ceftriaxone therapy in children: a prospective study.
Acun C; Erdem LO; Söğüt A; Erdem CZ; Tomaç N; Gündoğdu S; Cavuldak S
Ann Trop Paediatr; 2004 Mar; 24(1):25-31. PubMed ID: 15005963
[TBL] [Abstract][Full Text] [Related]
16. [Reversible ceftriaxone-associated biliary pseudolithiasis in three children with renal diseases].
Zhong XH; Chen H; Yao Y; Zhuo XW; Huang JP; Xiao HJ; Ai Y
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):216-9. PubMed ID: 20426960
[TBL] [Abstract][Full Text] [Related]
17. Ceftriaxone-associated nephrolithiasis in children.
Fesharakinia A; Ehsanbakhsh AR; Ghorashadizadeh N
Iran J Pediatr; 2013 Dec; 23(6):643-7. PubMed ID: 24910741
[TBL] [Abstract][Full Text] [Related]
18. Sonographic assessment of ceftriaxone-associated biliary pseudolithiasis in children.
Palanduz A; Yalçin I; Tonguç E; Güler N; Oneş U; Salman N; Somer A
J Clin Ultrasound; 2000 May; 28(4):166-8. PubMed ID: 10751736
[TBL] [Abstract][Full Text] [Related]
19. [Gallstones in association with the use of ceftriaxone in children].
Rodríguez Rangel DA; Pinilla Orejarena AP; Bustacara Diaz M; Henao García L; López Cadena A; Montoya Camargo R; Moreno LA
An Pediatr (Barc); 2014 Feb; 80(2):77-80. PubMed ID: 23759541
[TBL] [Abstract][Full Text] [Related]
20. Research Progress of Mechanisms of Ceftriaxone Associated Nephrolithiasis.
Wang S; Huang X; Xu Q; Xu T
Mini Rev Med Chem; 2017; 17(17):1584-1587. PubMed ID: 27488586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
